Claritev
CTEV on NYSE. Claritev sells healthcare cost data and analytics to healthcare organizations. Market value $418m.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Look carefully before going further
Why it could be worth it
Read the warning sign in its own filings
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-4.39 of spare cash in the past 12 months. A savings account pays about $4.
You pay 154.8 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 1 cents a year. Above 10 is good.
Quality score: 18 of 100. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.
$24.09 a share, 109% above its 1-year low
Over the past year the price has ranged from $11.50 to $73.68.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: a shortfall of $18 million in the past 12 months, a shortfall of $12 million in the year to December 2025.
| Revenue | |||||
| Revenue | $1.1bn | $1.1bn | $962m | $931m | $965m |
| Operating margin | |||||
| Operating margin | 34.5% | -33.6% | 16.8% | -149.4% | 3.0% |
| Debt to equity | |||||
| Debt to equity | 2.12 | 2.69 | 2.69 | 54.34 | n/a |
| Shares outstanding | |||||
| Shares outstanding | 0.64bn | 0.65bn | 0.02bn | 0.02bn | 0.02bn |
Health checks
- Free cash flow positive3 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)4 of 9
- Profit backed by cash (accruals)Yes
- DebtUnknown
- Revenue growth, five yearsSlow, 0.6% a year
- Buying back its own sharesYes, 97% fewer since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $257 million last quarter, up 7% on a year ago.
- A loss of $59 million, compared with a loss of $63 million a year ago.
- It keeps 3 cents of each $1 of sales as operating profit, after losing 38 cents a year earlier.
- Over the past 12 months it spent $18 million more cash than it brought in, compared with $55 million a year earlier.
- 3% more shares than a year ago. Each share owns a bit less of the company.
- Debt is $4.6 billion more than cash, up from $4.5 billion a year ago.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $230m |
| December 2024 | $232m |
| March 2025 | $231m |
| June 2025 | $242m |
| September 2025 | $246m |
| December 2025 | $247m |
| March 2026 | $245m |
| June 2026 | $257m |
| Quarter to | Amount |
|---|---|
| September 2024 | -$391m |
| December 2024 | -$138m |
| March 2025 | -$71m |
| June 2025 | -$63m |
| September 2025 | -$70m |
| December 2025 | -$81m |
| March 2026 | -$74m |
| June 2026 | -$59m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 26 February 2026
- Next quarterly (estimated, 10-Q)
- 6 November 2026
Who owns it
None of the long-term investors we follow own it. 102 funds in all.
Sold out this quarter
- Third PointDan LoebSold out
Largest holders overall
- H&F Corporate Investors VIII$133m
- Arini Capital Management$105mAdded
- Ares Management$64m
- Public Investment Fund$44m
- Beach Point Capital Management LP$26mCut
- BlackRock$25mAdded
- CPV Partners$17m
- Vanguard Capital Management$14m
- Prudential Financial$12m
- Geode Capital Management$8mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
4 investors own more than 5%.
- Hellman & Friedman Investors VIII, L.P.Passive investorat least 23.5%(filed with 10 related holders)Since 12 November 2025
What they said
Item 4 of the Schedule 13D is hereby amended and restated as follows: The Reporting Persons acquired the securities reported herein for investment purposes and intend to continue to review their investments in Claritev Corporation (the "Issuer") on an ongoing basis. Except as…
Read the filing - ASOF Investment Management LLCPassive investorat least 11.5%+6.0 pts(filed with 8 related holders)Since 5 February 2025
- Arini Capital Management LimitedPassive investorat least 9.1%+1.5 pts(filed with 5 related holders)Since 31 December 2025
- Leonard Green & Partners, L.P.Passive investorat least 4.8%(filed with 8 related holders)Since 14 January 2025
- GIC Private LimitedPassive investorSold down below 5%Since 22 September 2026
| Holder | Stake | Since | |
|---|---|---|---|
Hellman & Friedman Investors VIII, L.P. Passive investor | at least 23.5% (filed with 10 related holders) | 12 November 2025 | What they saidItem 4 of the Schedule 13D is hereby amended and restated as follows: The Reporting Persons acquired the securities reported herein for investment purposes and intend to continue to review their investments in Claritev Corporation (the "Issuer") on an ongoing basis. Except as… Read the filing |
ASOF Investment Management LLC Passive investor | at least 11.5%+6.0 pts (filed with 8 related holders) | 5 February 2025 | |
Arini Capital Management Limited Passive investor | at least 9.1%+1.5 pts (filed with 5 related holders) | 31 December 2025 | |
Leonard Green & Partners, L.P. Passive investor | at least 4.8% (filed with 8 related holders) | 14 January 2025 | |
GIC Private Limited Passive investor | Sold down below 5% | 22 September 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 7 insiders bought $2m of shares on the open market. 3 sold $919,345, $276,075 of it under preset trading plans.
- Garis Douglas MichaelEVP&CFOSoldunder a preset trading plan
- Date
- 21 September 2026
- Shares
- 9,025
- Price
- $30.59
- Value
- $276,075
- Dalton TravisPres., CEO & Executive Chair, DirectorBought
- Date
- 28 August 2026
- Shares
- 1,950
- Price
- $38.48
- Value
- $75,040
- Dalton TravisPres., CEO & Executive Chair, DirectorBought
- Date
- 27 August 2026
- Shares
- 4,500
- Price
- $38.81
- Value
- $174,623
- Misencik TiffaniSVP, Chief Growth OfficerSold
- Date
- 14 August 2026
- Shares
- 8,850
- Price
- $40.07
- Value
- $354,593
- Mintz William B.SVP, Chief Strategy OfficerSold
- Date
- 10 August 2026
- Shares
- 8,431
- Price
- $34.24
- Value
- $288,677
- Carol NutterSVP, Chief People OfficerBought
- Date
- 9 June 2026
- Shares
- 875
- Price
- $28.41
- Value
- $24,859
- Prince John MichaelDirectorBought
- Date
- 19 May 2026
- Shares
- 10,000
- Price
- $16.00
- Value
- $160,000
- Dalton TravisPres., CEO & Executive Chair, DirectorBought
- Date
- 18 May 2026
- Shares
- 20,920
- Price
- $12.36
- Value
- $258,638
- Kim MichaelEVP, Chief Digital OfficerBought
- Date
- 18 May 2026
- Shares
- 3,000
- Price
- $16.65
- Value
- $49,950
- Garis Douglas MichaelEVP&CFOBought
- Date
- 16 March 2026
- Shares
- 1,300
- Price
- $17.69
- Value
- $22,997
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 21 September 2026 | Garis Douglas Michael EVP&CFO | Sold under a preset trading plan | 9,025 | $30.59 | $276,075 |
| 28 August 2026 | Dalton Travis Pres., CEO & Executive Chair, Director | Bought | 1,950 | $38.48 | $75,040 |
| 27 August 2026 | Dalton Travis Pres., CEO & Executive Chair, Director | Bought | 4,500 | $38.81 | $174,623 |
| 14 August 2026 | Misencik Tiffani SVP, Chief Growth Officer | Sold | 8,850 | $40.07 | $354,593 |
| 10 August 2026 | Mintz William B. SVP, Chief Strategy Officer | Sold | 8,431 | $34.24 | $288,677 |
| 9 June 2026 | Carol Nutter SVP, Chief People Officer | Bought | 875 | $28.41 | $24,859 |
| 19 May 2026 | Prince John Michael Director | Bought | 10,000 | $16.00 | $160,000 |
| 18 May 2026 | Dalton Travis Pres., CEO & Executive Chair, Director | Bought | 20,920 | $12.36 | $258,638 |
| 18 May 2026 | Kim Michael EVP, Chief Digital Officer | Bought | 3,000 | $16.65 | $49,950 |
| 16 March 2026 | Garis Douglas Michael EVP&CFO | Bought | 1,300 | $17.69 | $22,997 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in Claritev’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 26 Feb 2026, plus the 10-Q filed 7 Aug 2026 and 8 later 8-Ks.
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of June 30, 2026, as a result of the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.”
Show the full paragraph
Under the supervision and with the participation of our management, including the Company’s principal executive officer and principal financial and accounting officer, the Company conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of June 30, 2026, as a result of the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
From the 10-Q filed 7 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
One big customer
Worth knowingOne customer brings in a big share of sales: 29.2% last year. Losing that customer would hurt.
“Two clients individually accounted for 29.2% and 10.4% of total revenues for the year ended December 31, 2025, and two clients individually accounted for 27.7% and 15.9% of total revenues for the year ended December 31, 2024.”
From the 10-K filed 26 February 2026, Item 1. Business. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- Sales have barely grown: 0.6% a year.
- It owes more than it owns on paper (negative equity). Often that's from borrowing to buy back shares.
- It isn't cheap on profits: 154.8× operating profit.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.